Sign in

You're signed outSign in or to get full access.

Guy Innes

Lead Independent Director at VOLITIONRX
Board

About Guy Innes

Guy Innes (age 68) is an independent director of VolitionRx (VNRX) who has served on the board since October 6, 2011 . He is a chartered accountant (ICAEW) with a long career in banking and private equity, including senior roles at Baring Brothers, Baring Private Equity Partners (London/Singapore), and Quartz Capital Partners (Head of Corporate Finance), and he holds a B.Sc. in Geography from Bristol University . He previously served as a director of Singapore Volition (2010–2015) prior to the share exchange .

Past Roles

OrganizationRoleTenureCommittees/Impact
Baring Brothers & Co. Limited (London/Paris)Investment banking – M&A, IPOs, capital raising1984–1995Executed/advised on cross-border M&A and capital markets transactions
Baring Private Equity Partners Limited (London/Singapore)Private equity – media/communications fund setup1995–1997Recruited managers and raised capital for Asian media/communications PE fund
Quartz Capital Partners Limited (London)Head of Corporate Finance1997–2000Led IPOs, private placements, M&A for technology companies
ProBio Inc.Director (biotech IP commercialization)2000–2006Board oversight of IP commercialization incl. transgenesis/cloning research
Carbon Mining PLCNon-executive Director2007–2010Board service (mineral exploration)
Magellan Copper & Gold PLCNon-executive Director2007–2010Board service (mineral exploration)
Singapore VolitionDirectorAug 18, 2010–Dec 15, 2015Pre-share exchange board role

External Roles

OrganizationRoleTenureNotes
The Innes Family Bare Trust 2023Trustee (for benefit of his children)CurrentHolds 1,400,000 VNRX shares; Mr. Innes is trustee
The Dill Faulkes Educational Trust Limited (DFET)Director and TrusteeCurrentHolds 356,000 VNRX shares; shares voting/dispositive control
Carbon Mining PLCNon-executive Director2007–2010Mineral exploration board
Magellan Copper & Gold PLCNon-executive Director2007–2010Mineral exploration board
ProBio Inc.Director2000–2006Biotech IP commercialization board

Board Governance

  • Committee leadership and memberships:
    • Audit Committee Chair; designated “Audit Committee financial expert” by the board .
    • Nominations & Governance Committee Chair during FY2024; following the 2025 Annual Meeting, Timothy Still becomes Chair and Mr. Innes remains a member .
    • Not listed as a Compensation Committee member; current comp committee members are independent directors (Nguyen, Henshall, Barnes, Rubin) .
  • Independence: The board determined Mr. Innes is independent under the NYSE American Company Guide; Audit Committee members meet heightened SEC independence criteria .
  • Attendance and engagement (FY2024):
    • Board met 5 times (12 actions by written consent); Audit met 5 times (6 consents); Compensation had no meetings (10 consents); Nominations & Governance met once (3 consents) .
    • All directors attended at least 75% of board and committee meetings during their service periods .
    • Six of eight directors attended the 2024 Annual Meeting .
  • Independent director executive sessions: at least annually without management/non-independent directors per NYSE American §802(c) .

Fixed Compensation (Director)

YearFees Earned or Paid in Cash ($)Notes
202343,363Standard quarterly retainer; see 2023 director comp table
202416,261Elected to forgo Q2–Q4 cash in exchange for RSUs; standard independent director agreement provides $10,840 per calendar quarter
  • Independent Director Agreement: Mr. Innes’ agreement (March 31, 2015) provides $10,840 per calendar quarter; between April 1, 2024 and December 31, 2024 he elected to forgo cash for RSUs granted on June 1, Sept 1, and Dec 1, 2024 .

Performance Compensation (Director Equity)

Grant DateInstrumentSharesGrant/Share Pricing ReferenceVesting Terms
Jun 1, 2024RSUs (in lieu of cash)16,022$0.7057 per share (pricing reference for 6/1 grants) Approx. one-third on Jun 1, 2024; Jul 1, 2024; Aug 1, 2024; additional time-based vesting in single installment on May 1, 2025
Sep 1, 2024RSUs (in lieu of cash)18,342$0.72 per share (pricing reference for 9/1 grants) Approx. one-third on Sep 1, 2024; Oct 1, 2024; Nov 1, 2024; additional time-based vesting in single installment on Jun 1, 2025
Dec 1, 2024RSUs (in lieu of cash)17,296$0.6949 per share (pricing reference for 12/1 grants) Approx. one-third on Dec 1, 2024; Jan 1, 2025; Feb 1, 2025; additional time-based vesting in single installment on Jul 1, 2025
Sep 28, 2023RSUs (annual grant)20,000$0.70 per share (all directors) Vests over 3 years in three equal installments at 12, 24, 36 months; subject to corporate performance goals and continued service
  • Options outstanding (as of Dec 31, 2024): Options to purchase 143,635 shares (exercisable within 60 days of April 25, 2025); no new option awards reported for 2024 .
  • Director compensation mix (Y/Y signal): Cash decreased materially in 2024 as Mr. Innes elected equity in lieu of cash; equity awards increased correspondingly, aligning compensation more with shareholder outcomes .

Other Directorships & Interlocks

Company/EntityPublic/PrivateRoleOverlap/Interlock Notes
Carbon Mining PLCPLC (mineral exploration)Non-executive Director (2007–2010)Prior external board; no interlock disclosed with VNRX stakeholders
Magellan Copper & Gold PLCPLC (mineral exploration)Non-executive Director (2007–2010)Prior external board; no interlock disclosed with VNRX stakeholders
ProBio Inc.Private (biotech IP commercialization)Director (2000–2006)Prior external board; no interlock disclosed with VNRX stakeholders
The Innes Family Bare Trust 2023TrustTrusteeHolds VNRX shares; see Equity Ownership
DFET (Educational Trust)Non-profit trustDirector/TrusteeHolds VNRX shares; see Equity Ownership

Expertise & Qualifications

  • Chartered accountant; member, Institute of Chartered Accountants in England and Wales .
  • Audit Committee financial expert (board designation) .
  • 30+ years in investment banking, private equity, and technology financing; prior Head of Corporate Finance at Quartz; M&A and capital markets execution at Baring Brothers .
  • B.Sc. in Geography, Bristol University .

Equity Ownership

CategorySharesNotes
Direct ownership733,243Shares held directly by Mr. Innes
Options (exercisable within 60 days of Apr 25, 2025)143,635Included in beneficial ownership per SEC rules
RSUs (settling within 60 days of Apr 25, 2025)34,364Included in beneficial ownership per SEC rules
Indirect – children (held directly)618,014Shares held by Mr. Innes’ children
Indirect – The Innes Family Bare Trust 20231,400,000Mr. Innes is trustee for benefit of his children
Indirect – DFET356,000Mr. Innes serves as director/trustee; shares voting/dispositive control
Total beneficial ownership3,285,256Represents 3.3% of 100,775,334 shares outstanding (as of Apr 25, 2025)
  • Shares pledged as collateral: No pledging is disclosed for Mr. Innes in the proxy sections reviewed .
  • Ownership guidelines: Not specified in the retrieved sections; beneficial ownership is presented per SEC rules .

Insider Trades and Capital Raises (Related-Party Context)

DateTransactionSecuritiesConsiderationGovernance Safeguard
Feb 22, 2023 (settlement)Participation in underwritten public offering234,000 common shares$409,500 aggregate ($1.75 per share public offering price)Reviewed and approved by the Audit Committee
  • March 2025 Registered Direct Offering: Directors and officers participated at $0.55 per share as a group, but the proxy explicitly details Lagoda’s participation; Mr. Innes is not specifically identified in the RDO participant list in the retrieved disclosure .

Governance Assessment

  • Strengths

    • Proven financial oversight: Audit Committee Chair and designated financial expert; led the committee’s 2024 audit review and recommendation to include audited financials in the 10-K .
    • Independence and attendance: Determined independent; attended at least 75% of meetings; board and committees met regularly (5 board; 5 audit) .
    • Alignment: Material beneficial ownership (3.3%); elected equity in lieu of cash in 2024, increasing at-risk, stock-based pay .
    • Governance refresh: Transitioning Nominations & Governance chair role to Still while retaining membership, signaling succession/refresh dynamics .
  • Watch items / potential conflicts

    • Indirect holdings via family trust and DFET where he has fiduciary roles (trustee/director) concentrate voting influence; monitor for any related-party transactions or voting conflicts (none beyond disclosed purchases) .
    • Long tenure (since 2011) can provide continuity but may raise independence-perception questions for some investors; the board maintains formal independence determinations annually .
  • Compensation structure signals

    • 2023→2024 shift from cash to equity (cash $43,363→$16,261; equity $16,093→$24,300; total $61,938→$40,561) indicates increased equity orientation and reduced guaranteed pay during 2024 .
    • RSU grants in 2024 are time-based and tied to serving in lieu of cash, with specific installment vesting dates that extend into 2025, supporting retention and alignment .

Director Compensation (Detail)

YearFees Earned/Paid in Cash ($)Stock Awards ($)Options ($)All Other ($)Total ($)
202343,363 16,093 2,482 61,938
202416,261 24,300 40,561

Notes:

  • 2015 Independent Director Agreement: $10,840 per calendar quarter; in 2024 Mr. Innes elected to forgo cash for RSUs for the three-month periods ended June 30, Sept 30, and Dec 31, 2024; see grant-by-grant vesting schedules above .
  • RSU pricing references: $0.7057 (Jun 1, 2024), $0.72 (Sep 1, 2024), $0.6949 (Dec 1, 2024) .

Equity Ownership & Alignment (Snapshot)

MetricValue
Total beneficial ownership3,285,256 shares (3.3% of outstanding as of Apr 25, 2025)
Direct vs. indirect733,243 direct; 2,374,014 indirect (children 618,014; Innes Family Bare Trust 1,400,000; DFET 356,000)
Derivatives143,635 options exercisable within 60 days; 34,364 RSUs settling within 60 days (both included in beneficial ownership)
PledgingNo pledging disclosed in retrieved proxy sections

Board Governance – Committee Charters and Policies

  • Audit Committee responsibilities include auditor oversight, internal controls, cybersecurity oversight, and related-party transaction approvals; Mr. Innes serves as Chair .
  • Compensation Committee charter includes oversight of executive/director pay programs and adoption/approval of the Clawback and Forfeiture Policy .
  • Nominations & Governance Committee responsibilities include board/committee composition, annual evaluations, conflict review for director positions, and ESG oversight/reporting guidance .

Governance Quality Bottom Line

  • Mr. Innes brings strong financial stewardship as Audit Chair and designated financial expert, with high meeting participation and independent status affirmed by the board .
  • His significant personal and family/trust holdings create meaningful skin-in-the-game but warrant monitoring for conflicts in any future related-party contexts; the only disclosed transaction was a pro-rata public offering purchase reviewed by the Audit Committee .
  • The migration toward equity-heavy director compensation in 2024 (forgoing cash for RSUs) is a positive alignment signal amid continued board refresh and committee leadership transitions .